Brain membrane phospholipid alterations in Alzheimer's disease.
Studies have demonstrated alterations in brain membrane phospholipid metabolite levels in Alzheimer's disease (AD). The changes in phospholipid metabolite levels correlate with neuropathological hallmarks of the disease and measures of cognitive decline. This 31P nuclear magnetic resonance (NMR) study of Folch extracts of autopsy material reveals significant reductions in AD brain levels of phosphatidylethanolamine (PtdEtn) and phosphatidylinositol (PtdIns), and elevations in sphingomyelin (SPH) and the plasmalogen derivative of PtdEtn. In the superior temporal gyrus, there were additional reductions in the levels of diphosphatidylglycerol (DPG) and phosphatidic acid (PtdA). The findings are present in 3/3 as well as 3/4 and 4/4 apolipoprotein E (apoE) genotypes. The AD findings do not appear to reflect non-specific neurodegeneration or the presence of gliosis. The present findings could possibly contribute to an abnormal membrane repair in AD brains which ultimately results in synaptic loss and the aggregation of A beta peptide.
Pettegrew
J W
JW
Department of Psychiatry. School of Medicine, University of Pittsburgh, Pennsylvania, USA. pettegre@pitt.edu
Panchalingam
K
K
Hamilton
R L
RL
McClure
R J
RJ
D000368:Aged; D000544:Alzheimer Disease / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D001057:Apolipoproteins E / Q000235:genetics; D001921:Brain / Q000378:metabolism* / Q000473:pathology; D005260:Female; D005838:Genotype; D005911:Gliosis / Q000473:pathology; D006801:Humans; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D008566:Membranes / Q000378:metabolism; D008875:Middle Aged; D010743:Phospholipids / Q000378:metabolism*; D012016:Reference Values; D014018:Tissue Distribution
D001057:Apolipoproteins E; D010743:Phospholipids